PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs
- PMID: 38831359
- PMCID: PMC11145858
- DOI: 10.1186/s13722-024-00476-4
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs
Abstract
Background: Women who engage in sex work and use drugs (WSWUD) experience disproportionate HIV risks. Substance use treatment bridge clinics offer an opportunity to increase HIV pre-exposure prophylaxis (PrEP) delivery to WSWUD, but research on best practices is lacking. Therefore, we explored facilitators and barriers to PrEP across the PrEP care continuum in these settings.
Methods: Bridge clinic and affiliated harm reduction health service providers and WSWUD from Boston were recruited using passive and active outreach between December 2021 and August 2022. Participants were invited to take part in semi-structured phone or in-person interviews to explore HIV prevention and PrEP care experiences overall and within bridge clinic settings. Deductive codes were developed based on HIV risk environment frameworks and the Information-Motivation-Behavioral Skills model and inductive codes were added based on transcript review. Grounded content analysis was used to generate themes organized around the PrEP care continuum.
Results: The sample included 14 providers and 25 WSWUD. Most WSWUD were aware of PrEP and more than half had initiated PrEP at some point. However, most who initiated PrEP did not report success with daily oral adherence. Providers and WSWUD described facilitators and barriers to PrEP across the steps of the care continuum: Awareness, uptake, adherence, and retention. Facilitators for WSWUD included non-stigmatizing communication with providers, rapid wraparound substance use treatment and HIV services, having a PrEP routine, and service structures to support PrEP adherence. Barriers included low HIV risk perceptions and competing drug use and survival priorities. Provider facilitators included clinical note templates prompting HIV risk assessments and training. Barriers included discomfort discussing sex work risks, competing clinical priorities, and a lack of PrEP adherence infrastructure.
Conclusion: WSWUD and bridge clinic providers favored integrated HIV prevention and substance use services in harm reduction and bridge clinic settings. Harm reduction and bridge clinic programs played a key role in HIV prevention and PrEP education for WSWUD. Effective behavioral and structural interventions are still needed to improve PrEP adherence for WSWUD.
Keywords: Drug Use; HIV Prevention; PrEP; Sex work; Women.
© 2024. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.Harm Reduct J. 2018 Nov 12;15(1):55. doi: 10.1186/s12954-018-0263-5. Harm Reduct J. 2018. PMID: 30419926 Free PMC article.
-
Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.BMC Public Health. 2021 Nov 27;21(1):2174. doi: 10.1186/s12889-021-12167-9. BMC Public Health. 2021. PMID: 34837988 Free PMC article.
-
HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.J Int AIDS Soc. 2024 May;27(5):e26252. doi: 10.1002/jia2.26252. J Int AIDS Soc. 2024. PMID: 38783534 Free PMC article.
-
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28. AIDS Patient Care STDS. 2020. PMID: 32109141 Free PMC article.
-
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.Harm Reduct J. 2023 Feb 13;20(1):16. doi: 10.1186/s12954-023-00729-6. Harm Reduct J. 2023. PMID: 36782321 Free PMC article. Review.
Cited by
-
HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?Curr HIV/AIDS Rep. 2025 Jan 15;22(1):13. doi: 10.1007/s11904-024-00721-0. Curr HIV/AIDS Rep. 2025. PMID: 39812953 Review.
References
-
- Centers for Disease Control and Prevention. HIV, surveillance report. 2021. 2023;34. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
-
- Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV Transmission in an urban setting: an outbreak of HIV infection among people who inject Drugs—Massachusetts, 2015–2018. Am J Public Health. 2020;110(1):37–44. doi: 10.2105/AJPH.2019.305366. - DOI - PMC - PubMed
-
- Bureau of Infectious Disease and Laboratory Sciences. Massachusetts HIV Epidemiologic Profile, Statewide Report – Data as of 1/1/2022 [Internet]. Boston: Massachusetts Department of Public Health. 2022 Feb [cited 2023 Oct 5]. https://www.mass.gov/lists/hivaids-epidemiologic-profiles
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous